Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 3
1977 1
1979 1
1982 1
1983 2
1985 1
1987 1
1988 1
1989 1
1990 1
1991 1
1992 1
1995 4
1996 2
1997 2
1998 2
1999 1
2000 3
2001 5
2002 2
2003 2
2004 1
2005 2
2006 1
2008 1
2009 1
2010 1
2011 1
2012 2
2013 1
2014 1
2015 2
2016 2
2017 1
2020 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Familial hemiplegic migraine: more than just a headache.
Benatar M, Ford CC. Benatar M, et al. Among authors: ford cc. Neurology. 2005 Feb 22;64(4):592-3. doi: 10.1212/01.WNL.0000152055.72402.F3. Neurology. 2005. PMID: 15728276 No abstract available.
Investigation of blast-induced traumatic brain injury.
Taylor PA, Ludwigsen JS, Ford CC. Taylor PA, et al. Among authors: ford cc. Brain Inj. 2014;28(7):879-95. doi: 10.3109/02699052.2014.888478. Epub 2014 Mar 21. Brain Inj. 2014. PMID: 24766453 Free PMC article.
Cultivating the Multiple Sclerosis Workforce of the Future.
DeLuca GC, Buckle G, Cortese I, Graves JS, Halper J, Newsome SD, Sicotte N, Ford CC; FCMSC MS Mentorship Forum Participants. DeLuca GC, et al. Among authors: ford cc. Int J MS Care. 2017 May-Jun;19(3):123-130. doi: 10.7224/1537-2073.2015-068. Int J MS Care. 2017. PMID: 28603460 Free PMC article.
Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study.
Ford CC, Cohen JA, Goodman AD, Lindsey JW, Lisak RP, Luzzio C, Pruitt A, Rose J, Rus H, Wolinsky JS, Kadosh SE, Bernstein-Hanlon E, Stark Y, Alexander JK. Ford CC, et al. Mult Scler. 2022 Oct;28(11):1729-1743. doi: 10.1177/13524585221094239. Epub 2022 Jun 29. Mult Scler. 2022. PMID: 35768939 Free PMC article. Clinical Trial.
Multivoxel 1H-MRS of stroke.
Ford CC, Griffey RH, Matwiyoff NA, Rosenberg GA. Ford CC, et al. Neurology. 1992 Jul;42(7):1408-12. doi: 10.1212/wnl.42.7.1408. Neurology. 1992. PMID: 1320220
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA; CARE-MS II Investigators. Giovannoni G, et al. Neurology. 2016 Nov 8;87(19):1985-1992. doi: 10.1212/WNL.0000000000003319. Epub 2016 Oct 12. Neurology. 2016. PMID: 27733571 Free PMC article. Clinical Trial.
57 results